Neos Therapeutics's competitors

Neos Therapeutics's competitors include RespireRx Pharmaceuticals, Akorn, Daiichi Sankyo and Adamas Pharmaceuticals
Add company...
Neos Therapeutics
Neos Therapeutics is an oral drug delivery company developing controlled time-release technologies.
RespireRx Pharmaceuticals
RespireRx Pharmaceuticals Inc. is a biopharmaceutical company focused on the discovery and development of novel drug therapies for the treatment of sleep apnea, drug-induced respiratory depression and other brain-mediated breathing disorders.
Akorn
Akorn is a niche pharmaceutical company that develops, manufactures and markets generic and branded prescription pharmaceuticals as well as animal and consumer health products.
Daiichi Sankyo
Daiichi Sankyo develops and markets pharmaceuticals.
Adamas Pharmaceuticals
Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.
Founding Date
Founding Date
2008
Founding Date
1988
Founding Date
1948
Founding Date
N/A
Founding Date
2002
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Grand Prairie, US HQ
Blue Bell, US
Locations
Glen Rock, US HQ
Locations
Lake Forest, US HQ
Gurugram, IN
Jersey, JE
Brooklyn, US
Queens, US
Houston, US
Ann Arbor, US
Locations
Parsippany-Troy Hills, US HQ
Locations
Emeryville, US HQ
Employees
Employees
134
Employees
1
Employees
2,261
Employees
3,168
Employees
8415% increase
Valuation ($)
Valuation ($)
200.1 m
Valuation ($)
2.3 m
Valuation ($)
1.8 b
Valuation ($)
14.7 b
Valuation ($)
791.9 m

Financial

Revenue (est.)
Revenue (est.)
$9.2m (FY, 2016)
Revenue (est.)
N/A
Revenue (est.)
$841m (FY, 2017)
Revenue (est.)
N/A
Revenue (est.)
$572k (FY, 2016)
Cost of goods
Cost of goods
$11.4m (FY, 2016)
Cost of goods
N/A
Cost of goods
$407.9m (FY, 2017)
Cost of goods
N/A
Cost of goods
N/A
Gross profit
Gross profit
($2.3m) (FY, 2016)
Gross profit
N/A
Gross profit
$433.1m (FY, 2017)
Gross profit
N/A
Gross profit
N/A
Net income
Net income
($83.3m) (FY, 2016)
Net income
($4.3m) (FY, 2017)
Net income
($24.6m) (FY, 2017)
Net income
N/A
Net income
($60.1m) (FY, 2016)

Funding

Total funding raised
Total funding raised
$ 24.1m
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 82m
For sources of this data, please see the company profileDownload Excel

View company profiles

RespireRx Pharmaceuticals
HQ
Glen Rock, US
Employees
1

RespireRx Pharmaceuticals Inc. is a biopharmaceutical company focused on the discovery and development of novel drug therapies for the treatment of sleep apnea, drug-induced respiratory depression and other brain-mediated breathing disorders.

View company
Akorn
HQ
Lake Forest, US
Employees
2,261

Akorn is a niche pharmaceutical company that develops, manufactures and markets generic and branded prescription pharmaceuticals as well as animal and consumer health products.

View company
Daiichi Sankyo
HQ
Parsippany-Troy Hills, US
Employees
3,168

Daiichi Sankyo develops and markets pharmaceuticals.

View company
Adamas Pharmaceuticals
HQ
Emeryville, US
Employees
84↑ 15% increase

Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.

View company